verapamil has been researched along with fulvestrant in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dubrovskyi, O; Dye, K; Gutgesell, LM; Huang, F; Li, Y; Ratia, K; Shen, Z; Thatcher, GRJ; Tonetti, DA; Xiong, R; Zhao, H; Zhao, J | 1 |
| Glusa, E; Gräser, T; Oettel, M; Wagner, S | 1 |
| Chen, YC; Lin, T; Nagpal, ML; Stocco, DM | 1 |
1 review(s) available for verapamil and fulvestrant
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for verapamil and fulvestrant
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.
Topics: Animals; Breast Neoplasms; Drug Resistance, Neoplasm; Fulvestrant; Humans; MCF-7 Cells; Mice; Models, Molecular; Piperazines; Protein Domains; Pyridines; Pyridones; Receptors, Estrogen; Tissue Distribution; Transcription Factors; Xenograft Model Antitumor Assays | 2020 |
Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins.
Topics: Animals; Aorta, Thoracic; Chlormadinone Acetate; Endothelium, Vascular; Estradiol; Estrogen Antagonists; Fulvestrant; Hormone Antagonists; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nandrolone; Norethindrone; Phenylephrine; Progesterone; Progesterone Congeners; Rats; Rats, Wistar; Time Factors; Vasoconstrictor Agents; Vasodilator Agents; Verapamil | 1997 |
Effects of genistein, resveratrol, and quercetin on steroidogenesis and proliferation of MA-10 mouse Leydig tumor cells.
Topics: Adenosine Triphosphatases; Animals; Calcium Channel Blockers; Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Egtazic Acid; Estradiol; Fulvestrant; Genistein; Leydig Cells; Male; Mibefradil; Mice; Phosphoproteins; Phytoestrogens; Progesterone; Quercetin; Receptors, Estrogen; Resveratrol; RNA, Messenger; Stilbenes; Stimulation, Chemical; Vanadates; Verapamil | 2007 |